Training for Academic Hematology

描述(由申请人提供)： 这份申请是为了竞争性地续签加州大学洛杉矶分校大卫·格芬医学院的PHS机构国家服务奖，为血液学的学术生涯做准备。该奖项于2002年7月设立，在第二年和第三年的血液学/内科肿瘤学培训中支持4个奖学金名额。在参加该计划的11名研究员中，4名目前正在接受培训，7名已完成研究员资格，其中4名是加州大学洛杉矶分校的全职教员，2名在行业中进行临床试验开发，1名已进入临床实践。该学院由31名科学家和内科医生组成，分为四个共同研究领域：血液学和干细胞生物学(Kenneth Dorshkind，博士，主任)、白血病(Gary Schiller，医学博士，主任)、淋巴细胞生物学和淋巴瘤(Alan Lichstein，医学博士，主任)和止血、血栓和血管生物学(Victor Marder，医学博士，主任)。所有教职员工都有校外研究资助，其中24人(77%)获得了NIH的资助。与互补学科的其他培训项目的互动强调了我们互动基础研究和翻译研究职业的目标。每年春天都会举行一次研究务虚会，在此期间，每个导师都会介绍实验室的研究兴趣，然后是各自研究员的进展报告。对导师的有效性以及研究员的进展和目标的正式审查由指导委员会准备，该委员会由四名重点主任组成。向所有研究员提供核心课程，包括“临床研究课程”，该课程涵盖研究设计和分析、伦理、监管、问题、拨款准备和负责任的研究行为等主题。作为STAR计划的一部分，研究员被鼓励获得高级学位，并在适当的部门进行一到两年的正规课程工作。在2002年至今期间完成课程的7名研究员中，2人获得了硕士学位，1人获得了博士学位。对于加州大学洛杉矶分校的大卫·格芬医学院来说，培训具有基础、临床和转化性研究专业知识的血液学家是一个重要的优先事项，这项申请寻求在临床培训和最终在血液学学术生涯之间的关键时期提供支持。

DESCRIPTION (provided by applicant): This application is for competitive renewal of a PHS Institutional National Service Award at the David Geffen School of Medicine at UCLA to prepare fellows for an academic career in Hematology. This award was initiated in July, 2002, and supports 4 fellowship slots in years 2 and 3 of Hematology/Medical Oncology training. Of 11 fellows who have entered the program, 4 are currently in training and 7 have completed their fellowship, of which 4 are on the full-time faculty at UCLA, two are in clinical trial development with industry, and one has entered clinical practice. The faculty consists of 31 academic scientists and physicians, grouped into four areas of mutual research interest, Hematopoiesis and Stem Cell Biology (Kenneth Dorshkind, PhD, Director), Leukemia (Gary Schiller, MD, Director), Lymphocyte Biology and Lymphoma (Alan Lichtenstein, MD, Director) and Hemostasis, Thrombosis and Vascular Biology (Victor Marder, MD, Director). The entire faculty have extramural research grant support, including 24 (77%) with NIH grants. Interaction with other training programs in complementary disciplines emphasizes our goal of interactive basic and translational research careers. A research retreat is; held each spring, during which time each mentor presents an overview of the laboratories' research interest, followed by a report of the respective fellows' progress. Formal review of the mentor's effectiveness and the fellow's progress and goals are prepared by the Steering Committee, made up of the four Focus Directors. A core curriculum is offered to all fellows, including a "Clinical Research Course", which covers subjects on research design and analysis, ethics, regulatory, issues, grant preparation and responsible conduct of research. Fellows are encouraged to obtain an advanced degree as part of the STAR program, with formal course work in appropriate departments for one or two additional years. Of the 7 fellows who have completed their program during the interval 2002 - present, 2 have obtained the Master's degree and 1 has received a PhD degree. The training of hematologists with expertise in basic, clinical and translational research is an important priority for the David Geffen School of Medicine at UCLA and this application seeks support for the pivotal period between clinical training and an eventual career in academic hematology.